January 7, 2008 NASD OTC-BB: MRDAF (MARKET WIRE)

LAPEX 2000 LipoLaser Gaining Attention With Canadian News Media

Meridian Co., Ltd. ("Meridian") (OTC BB:MRDAF.OB - News) was recently approved for safe and effective fat reduction by Health Canada, the LAPEX 2000 LipoLaser (or LipoLaser) is gathering positive feedback from national Canadian news outlets as well as the Canadian medical and aesthetics markets.

"The LipoLaser is truly an amazing product for measurable inch loss and spot fat reduction," states Anna Brazier, President of Belgium Medical Inc., the exclusive North American distributor for the LipoLaser. "I am pleased that Canadians now have the option of a non-invasive procedure that can be used as a stand alone treatment or to enhance any diet or weight loss program that they may be considering."

On December 27th, The Globe and Mail featured an article entitled "Zapping Away the Fat" that discussed the benefits of the LipoLaser versus more invasive and life threatening fat reduction procedures such as liposuction. The complete article can be viewed at: https://meridianmedical.ca/site/news/NR122707.pdf.

More recently, the LipoLaser was featured on CKNW NewsTalk 980 with Dr. Jonas LaForge, Naturopathic Physician and Belgium Medical Inc.'s Director of Medical Sales. A LipoLaser patient who has successfully lost four inches off her abdominal area was also featured on the show.

This month, the LipoLaser will also be highlighted in a seven page spread in Spa Canada Magazine which produces six issues per year and is distributed to 12,000 medi-spas and individual trade professionals nationwide.

Meridian Co., Ltd. and Belgium Medical Inc. are working together to spread the great news about the health and wellness benefits of LipoLaser throughout Canada and look forward to other media launches throughout the globe.

More About: LAPEX 2000 LipoLaser

The LAPEX 2000 LipoLaser was designed to target the medical and aesthetic market, specifically to address inch loss and spot fat reduction. The LAPEX 2000 LipoLaser's non-invasive treatment is considered one of the most innovative methods to treat stubborn areas of fat. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession but in any clinical setting such as medi-spas and wellness centers. To receive more information about the LAPEX 2000 LipoLaser email [email protected].

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received approvals from FDA and other international regulatory agencies for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan, Mexico and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: https://MeridianMedical.ca